First Trust Capital Management L.P. Harvard Bioscience Inc Transaction History

First Trust Capital Management L.P.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2020 May 15, 2020	SELL	$1.42 - $3.29 $62,974 - $145,904	-44,348 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$2.45 - $3.25 $108,652 - $144,131	44,348 New	44,348 $135,000

30.6M

700

2.1K

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $89.1M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

Get notified when there are updates to the investment portfolio of First Trust Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on First Trust Capital Management L.P. with notifications on news.